Ken Harris: Why AI and automation are CGT’s next inflection point

About this episode

Ken Harris discusses the role of AI and automation in scaling CAR-T therapies in healthcare.

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Ken Harris, CEO of Omnia Bio and former healthcare lead at Amazon Web Services, to explore what it will take to scale CAR-T from hundreds to millions. Drawing on 35 years in healthcare, Ken shares how AI, automation, and digital infrastructure can help streamline manufacturing and support consistent delivery. They unpack the economic reality behind CGT access, the need for smarter clinical trial design, and why a more integrated system is essential to move beyond bespoke solutions.

People in this episode

Host: Jason C. Foster

Guest: Ken Harris

Topics covered

• AI
• automation
• CAR-T
• CGT
• healthcare
• manufacturing
• clinical trials

Keywords

• AI
• automation
• CAR-T
• CGT
• healthcare
• manufacturing
• clinical trials
• digital infrastructure
• economic reality
• integrated system

Mentioned in this episode

Organizations: Omnia Bio, Amazon Web Services

More episodes of Ori Spotlight

• Joe DePinto: Why advanced therapies need a new delivery model · January 13, 2026 · 1h 5m
• Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy · December 16, 2025 · 56 min
• John Khoury: The CGT developers who adapt new manufacturing techniques early will lead later · December 3, 2025 · 50 min
• Warner Biddle: Building a commercial model for CAR-T in autoimmune care · September 2, 2025 · 41 min
• Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success · August 12, 2025 · 1h 0m
• Henrik Andersen: How smart planning helps CGT scale further, faster · July 15, 2025 · 54 min